Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Bezafibrate [1] BEZAFIBRATE[1] D01366 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[7] 20, 93, 94, 160, 296, 316, 324
2 Glycerin [3] Bee venom; Glycerine; Glycerol[1] D00028 --[6] 6, 13, 79, 265, 316, 317
3 Heparin [2] Heparin; HEPARIN SODIUM[1] D07510 [1] SERPINC1 💬[1] Complement and coagulation cascades 💬[12] 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317
4 Levocarnitine [4] Carnitine; L-Carnitine; LEVOCARNITINE; Xyzal[3] D02030 ,
D02176 ,
D04713
--[11] 3, 5, 13, 53, 58, 86, 96, 97, 265, 298, 316